Saturday 17 October 2026 Export IMDX’s income statement to Excel — free account

Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 million, up 115.6% from fiscal 2024. In the quarter to June 2026, revenue fell 53.9%, EPS fell 3.33% and free cash flow fell 54.0%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

3.01 0.05 −1.63%

Follow IMDX

Alert me

Market cap: $100.1M
P/E: 0.0×
Fwd P/E: −6.4×
Dividend yield: —
F-score: 3/9
Altman Z: −25.63
Beneish M: −7.73
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	1	2	4	5	+8 more TTM periods Free account
ROE Full definition →	488.68%	20,228.75%	229.65%	(23,500.97%)
ROA Full definition →	(123.46%)	(94.93%)	(165.10%)	(106.02%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(303.54%)	(174.46%)	(519.57%)	(338.53%)
Average Days of Receivables Full definition →	41.96	29.40	101.53	21.39
Free Cash Flow per Share Full definition →	(0.84)	(0.80)	(0.83)	(0.75)
Free Cash Flow Full definition →	(31.00)	(27.47)	(25.37)	(23.91)
Capital Expenditures Full definition →	(3.92)	(3.49)	(3.18)	(1.92)
Other line items
Cash ROIC Full definition →	1,632.39%	(150.64%)	145.28%	(233.80%)
Accounts Receivable Turnover Full definition →	4.74	1.05	2.96	18.85
Accounts Payable Turnover Full definition →	0.55	0.49	0.84	2.08
Inventory Turnover Full definition →	1.92	2.29	4.11	5.70
Average Days of Payables Full definition →	791.33	613.40	528.49	192.24
Days of Inventory on Hand Full definition →	87.55	145.09	92.65	85.74
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	1,146.47%	919.91%	392.11%	280.05%
Selling, General and Administrative Expense of Revenue Full definition →	1,121.56%	926.01%	418.64%	366.20%
Share Based Compensation of Revenue Full definition →	150.78%	121.14%	54.72%	45.37%
Interest Coverage Full definition →	(513.24)	(473.18)	(469.03)	(542.62)
Operating CF/Net income Full definition →	0.55	0.50	0.44	0.36
Depreciation/Fixed assets Full definition →	0.41	0.26	0.34	0.53
Capex/Depreciation Full definition →	(1.60)	(1.49)	(1.45)	(0.87)
Revenue per Share Full definition →	0.05	0.06	0.13	0.14
Operating CF per Share Full definition →	(0.74)	(0.69)	(0.73)	(0.69)
Capex per Share Full definition →	(0.11)	(0.10)	(0.10)	(0.06)
Capex to Sales Full definition →	2.35	1.79	0.79	0.44

Show all line items

Columns are period end dates

Stockrow Weekly